Dual effects of interleukin-18: Inhibiting hepatitis B virus replication in Hepg2.2.15 cells and promoting hepatoma cells metastasis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 301, Issue 3, 2011, Pages

  Zhang, Yijuan ^a   Li, Yunbo ^a   Ma, Yifan ^b   Liu, Shuhui ^a   She, Yinglong ^a   Zhao, Peng ^a   Jing, Mingzhen ^a   Han, Tao ^a   Yan, Chao ^b   Wu, Zhenghui ^a   Gao, Jinrong ^a   Ye, Linbai ^a  

^a WUHAN UNIVERSITY   (China)

^b SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

Author keywords

Extracellular matrix metalloproteinases; Hepatitis B virus; Hepatoma cells; Interleukin 18; Metastasis and migration

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; MESSENGER RNA; STROMELYSIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CANCER TISSUE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UPREGULATION; VIRUS REPLICATION;

CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL MOVEMENT; HEP G2 CELLS; HEPATITIS B VIRUS; HUMANS; INTERLEUKIN-18; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; NEOPLASM METASTASIS; NF-KAPPA B; RECEPTORS, INTERLEUKIN-18; RNA, MESSENGER; UP-REGULATION; VIRUS REPLICATION;

EID: 80052291995     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00058.2011     Document Type: Article

References (24)

1. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol 12: 59-63, 2000.
2. Channarong S, Mitrevej A, Sinchaipanid N, Usuwantim K, Kulkeaw K, Chaicumpa W. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine. Asian Pac J Allergy Immunol 25: 233-242, 2007.
3. Chen JZ, Zhu HH, Liu KZ, Chen Z. Enhancing cellular immune response to HBV M DNA vaccine in mice by codelivery of interleukin-18 recombinant. J Zhejiang Univ Sci 5: 467-471, 2004.
4. Cheong JY, Cho SW, Oh B, Kimm K, Lee KM, Shin SJ, Lee JA, Park BL, Cheong HS, Shin HD, Cho BY, Kim JH. Association of interleukin-18 gene polymorphisms with hepatitis B virus clearance. Dig Dis Sci 55: 1113-1119, 2010.
5. Demeule M, Brossard M, Pagé M, Gingras D, Béliveau R. Matrix metalloproteinase inhibition by green tea catechins. Biochim Biophys Acta 1478: 51-60, 2000.
6. Halpern MD, Holubec H, Dominguez JA, Meza YG, Williams CS, Ruth MC, McCuskey RS, Dvorak B. Hepatic inflammatory mediators contribute to intestinal damage in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 284: G695-G702, 2003.
7. Hirankarn N, Manonom C, Tangkijvanich P, Poovorawan Y. Association of interleukin-18 gene polymorphism (-607A/A genotype) with susceptibility to chronic hepatitis B virus infection. J Cell Biochem 70: 160-163, 2007.
8. Jiang D, Ying W, Lu Y, Wan J, Zhai Y, Liu W, Zhu Y, Qiu Z, Qian X, He F. Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics 3: 724-737, 2003.
9. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67, 2010.
10. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol 76: 10702-10707, 2002.
11. Li J, Ou JH. Differential regulation of hepatitis B virus gene expression by the Sp1 transcription factor. J Virol 75: 8400-8406, 2001.
12. Lin SS, Wu M, Xu Y, Xiong W, Yi ZG, Zhang XN, Zhenghong Y. Inhibition of hepatitis B virus replication by MyD88 is mediated by nuclear factor-kappaB activation. Biochim Biophys Acta 1772: 1150-1157, 2007.
13. Lin YC, Hsu EC, Ting LP. Repression of hepatitis B viral gene expression by transcription factor nuclear factor-kappaB. Cell Microbiol 11: 645-660, 2009.
14. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 12: 53-72, 2001.
15. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10: 127-136, 1999.
16. Park S, Cheon S, Cho D. The dual effects of interleukin-18 in tumor progression. Cell Mol Immunol 4: 329-335, 2007.
17. Reddy P. Interleukin-18: recent advances. Curr Opin Hematol 11: 405-410, 2004.
18. Sato H, Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 81993: 395-405, 1993.
19. Subramaniam S, Stansberg C, Cunningham C. The interleukin 1 receptor family. Dev Comp Immunol 28: 415-428, 2004.
20. Szkaradkiewicz A, Jopek A, Wysocki J. Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection. Antiviral Res 66: 23-27, 2005.
21. Tangkijvanich P, Thong-Ngam D, Mahachai V, Theamboonlers A, Poovorawan Y. Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma. World J Gastroenterol 13: 4345-4349, 2007.
22. Vidal-Vanaclocha F, Mendoza L, Telleria N, Salado C, Valcárcel M, Gallot N, Carrascal T, Egilegor E, Beaskoetxea J, Dinarello CA. Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression. Cancer Metastasis Rev 25: 417-434, 2006.
23. Xiong W, Wang X, Liu XY, Xiang L, Zheng LJ, Yuan ZH. Interferoninducible MyD88 protein inhibits hepatitis B virus replication. Virology 319: 306-314, 2004.
24. Yu X, Mertz JE. Differential regulation of the Pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily. J Virol 71: 9366-9374, 1997.